Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival

Journal of Ovarian Research

Volumn 3, Issue 1, 2010, Pages

  Nodin, Björn ^a   Zendehrokh, Nooreldin ^a   Brändstedt, Jenny ^a   Nilsson, Elise ^a   Manjer, Jonas ^a,b   Brennan, Donal J ^c   Jirström, Karin ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CLINICAL FEATURE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; TISSUE MICROARRAY; UTERINE TUBE;

EID: 77954568141     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-3-14     Document Type: Article

References (18)

1. Cancer statistics, 2009. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun, CA Cancer J Clin 2009 59 4 225 49 10.3322/caac.20006 19474385
2. Serum gonadotropins and steroid hormones and the development of ovarian cancer. KJ Helzlsouer AJ Alberg GB Gordon C Longcope TL Bush SC Hoffman GW Comstock, Jama 1995 274 1926 1930 10.1001/jama.274.24.1926 8568986
3. The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. EG Silva C Tornos HA Fritsche Jr A el-Naggar K Gray NG Ordonez M Luna D Gershenson, Mod Pathol 1997 10 879 883 9310950
4. Androgen, progesterone and FSH receptor polymorphisms and ovarian cancer risk and outcome. A Ludwig M Murawska G Panek A Timorek J Kupryjanczyk, Endocr Relat Cancer 2009 19458022
5. Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer. JM Schildkraut SK Murphy RT Palmieri E Iversen PG Moorman Z Huang S Halabi B Calingaert A Gusberg JR Marks A Berchuck, Cancer Epidemiol Biomarkers Prev 2007 16 473 480 10.1158/1055-9965.EPI-06-0868 17372242
6. Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study. MR Cardillo E Petrangeli N Aliotta L Salvatori L Ravenna C Chang G Castagna, J Exp Clin Cancer Res 1998 17 231 237 9700586
7. An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors. S Chadha BR Rao BJ Slotman CC van Vroonhoven TH van der Kwast, Hum Pathol 1993 24 90 95 10.1016/0046-8177(93)90067-Q 8418017
8. Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer. P Lee DG Rosen C Zhu EG Silva J Liu, Gynecol Oncol 2005 96 671 677 10.1016/j.ygyno.2004.11.010 15721410
9. Expression of human estrogen receptor-alpha and-beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. KM Lau SC Mok SM Ho, Proc Natl Acad Sci USA 1999 96 5722 5727 10.1073/pnas.96.10.5722 10318951
10. The cell of origin of ovarian epithelial tumours. L Dubeau, Lancet Oncol 2008 9 1191 1197 10.1016/S1470-2045(08)70308-5 19038766
11. The Malmo Diet and Cancer Study. Design and feasibility. G Berglund S Elmstahl L Janzon SA Larsson, J Intern Med 1993 233 45 51 10.1111/j.1365-2796. 1993.tb00647.x 8429286
12. Cardiovascular risk groups and mortality in an urban swedish male population: the Malmo Preventive Project. G Berglund KF Eriksson B Israelsson T Kjellstrom F Lindgarde I Mattiasson JA Nilsson L Stavenow, J Intern Med 1996 239 489 497 10.1046/j.1365-2796.1996.483819000.x 8656142
13. REporting recommendations for tumour MARKer prognostic studies (REMARK). LM McShane DG Altman W Sauerbrei SE Taube M Gion GM Clark, Eur J Cancer 2005 41 1690 1696 10.1016/j.ejca.2005.03.032 16043346 (Pubitemid 41132629)
14. Tissue microarrays for high-throughput molecular profiling of tumor specimens. J Kononen L Bubendorf A Kallioniemi M Barlund P Schraml S Leighton J Torhorst MJ Mihatsch G Sauter OP Kallioniemi, Nat Med 1998 4 844 847 10.1038/nm0798-844 9662379
15. Ovarian carcinoma subtypes are different diseases implications for biomarker studies. M Kobel SE Kalloger N Boyd S McKinney E Mehl C Palmer S Leung NJ Bowen DN Ionescu A Rajput, et al. PLoS Med 2008 5 232 10.1371/journal.pmed. 0050232 19053170
16. The human ovarian surface epithelium is an androgen responsive tissue. RJ Edmondson JM Monaghan BR Davies, Br J Cancer 2002 86 879 885 10.1038/sj.bjc.6600154 11953818
17. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. JW Carlson A Miron EA Jarboe MM Parast MS Hirsch Y Lee MG Muto D Kindelberger CP Crum, J Clin Oncol 2008 26 4160 4165 10.1200/JCO.2008.16.4814 18757330
18. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. Y Lee A Miron R Drapkin MR Nucci F Medeiros A Saleemuddin J Garber C Birch H Mou RW Gordon, et al. J Pathol 2007 211 26 35 10.1002/path.2091 17117391